The Stamet Stack: A monthly supply:

Although the protocol seems a catch-all between increasing “creativity, cognition, PTSD, and regeneration of vision and auditory neurons“, in truth the objective of the stack is primarily to increase neurogenesis in the brain over time so as to preserve memories.

Neurogenesis — the creation of new brain cells — occurs of course at a great rate in the very young. For a long time, it was not thought to occur in adult brains — once you were grown, it was thought, all you could do was watch your brain cells die!

The protocol include a full month’s worth of capsules, including the Lion’s Mane encapsulated extract, Niacin, and the active Magic Mushroom powder.

Just take 1 capsule each day for 5 days and then take 2 days off.  

The protocol is pre-made for you to be very simple. J The niacin, magic mushroom, and the Lion’s mane are pre-measured in the capsules for each day to maximize the benefits. It includes Lions mane dosage every day, Niacin and Magic Mushroom capsules each weekday.

Scooby Snack:

These are capsules are filled with psilocybin 0.2 grams and various other herbs, plants,  and extracts.

This synergistic blend provides the user with a creative, up lighting and energetic experiences. The flex dose. 

Ideal for being active, working on creative projects, going out with friends. It’s enough to feel the mushroom and to enjoy the benefits of super foods/brain food to balance out the experience. The formulated blend is ideal when you don’t want to trip, but you want to feel the positive experiences of tripping. 

Mushroom: Golden Teachers:

Fans of magic mushrooms agree that the Golden Teacher mushrooms, also known as a strain of Psilocybe cubensis, is the most popular psychedelic mushroom strain

Golden Teacher shrooms have a fruiting body with a distinguishable, slightly curved cap, with a yellow or golden center. Overall, this shroom has a cap with an ashy red color and can reach up to 8 cm in diameter. They have a hollow stripe which is thicker towards the base. They also have gills which vary from whitish to purple brown.

Golden Teachers are fairly new and they first appeared during the 1980’s. The exact origins are unknown but it is highly recognizable because of its golden caps with specks of yellow. Compared to most strains of Psilocybe cubensis, Golden Teachers have larger stems and caps; and a generally more elegant appearance.

How do Golden Teachers look like?

Golden Teacher shrooms have a fruiting body with a distinguishable, slightly curved cap, with a yellow or golden center. Overall, this shroom has a cap with an ashy red color and can reach up to 8 cm in diameter. They have a hollow stripe which is thicker towards the base. They also have gills which vary from whitish to purple brown.

Golden Teacher dosage

The recommended dose for dried Golden Teacher mushrooms is between 1 gram and 2.5 grams. For most experienced shroomers, this dose may be quite small but this allows a margin of error for novice shroomers who never ingested Golden Teachers before.

Tripping on Golden Teacher shrooms

Those who are new to the world of psychedelics and shrooms can count on Golden Teachers for a reliable trip with lesser chances of having a bad trip. Hence, they are often a gateway shroom for magic mushroom newbies.

Golden teachers are also laud for their spiritual and/or shamanic effects. Hence, this shroom isn’t just for casual tripping. It can also be used for gaining new insight about yourself and the universe.

It’s not uncommon for the Golden Teacher shrooms to produce a feeling of enlightenment and a deeper connection to nature. Spirit healers turn to Golden teacher shrooms as tools for restoring the mind and spirit.

Finally, Golden Teachers also produce hallucinogenic effects – a trait common among all magic mushrooms. Expect a visionary experience along with waves of universal energy surging through you with strong open and closed eye hallucinations.

The name “Golden Teacher” derives from the magic mushroom’s ability to teach by providing new psychedelic experiences and transcendence to the shroomers. There’s no education higher than unraveling the mysteries of the universe.

Tripping on Golden Teachers guidelines

As psychedelics with the ability to heal the mind and spirit, Golden Teachers need to be treated with respect and refrain from abusing the power they possess. Always be responsible. Here are some useful tips when tripping on Golden teachers:

If you’re tripping for the first time, it’s best to have a trip sitter nearby. A trip sitter should remain sober and watch over you to help out in the event of an emergency.

Never exceed the recommended Golden Teacher dose.

Don’t mix Golden Teachers with weed or other substances even if you are an experienced tripper.

Have some Vitamin C nearby to help you recover from the effects in case your dose is stronger than intended.

Drink a lot of water after the trip to help flush the psilocybin out of your system and to be able to return to your day-to-day self much quicker. 


Guide to using Magic Mushrooms safely

How Magic Mushrooms Change Your Brain

Psilocybin is a chemical found in magic mushrooms that causes the user to experience a sensory overload of saturated colors and patterns. Recent research has found that this effect happens because the brain becomes “hyperconnected” and allows for increased communication between different regions. It is hoped that this ability can be manipulated in order to manufacture drugs to treat neurological conditions. The paper was published in an open access format in the Journal of the Royal Society Interface with Giovanni Petri of Italy’s ISI Foundation serving as lead author. 

The chemical works by binding the same receptors in the brain as the neurotransmitter serotonin. This allows the drug to alter mood. While many people have a happy, meaningful experience, some can have a “bad trip” and experience extreme paranoia  Prior studies have found that that getting high on psilocybin doesn’t just create a colorful, psychedelic experience for a couple of hours; it can cause neurological changes that last over a year. These changes resulted in a personality that was more open to the creative arts and became happier, even 14 months after receiving the psilocybin. 

Though previous research surmised that psilocybin decreased brain activity, the current study used functional magnetic resonance imaging (fMRI) to see what was really going on. The study used 15 participants with prior positive experiences with hallucinogens to avoid a bad trip inside the enclosed machine. Some of the participants received psilocybin, while the other half received a saline placebo.

Simplified illustration of the connections tracked while receiving the placebo (a) and the psilocybin (b). Image credit: Petri et al., 2014.

Surprisingly, the researchers saw that upon receiving psilocybin, the brain actually re-organized connections and linked previously unconnected regions of the brain. These connections were not random, but appeared very organized and stable. Once the drug wore off, the connections returned to normal. 

“We can speculate on the implications of such an organization. One possible by-product of this greater communication across the whole brain is the phenomenon of synesthesia which is often reported in conjunction with the psychedelic state,” the authors wrote. 

Synesthesia is a subconscious pairing of two things, like colors and numbers. Someone experiencing this phenomenon might always view the number 2 as green or read 6 and think of the color purple. Because of these strange associations, individuals taking psilocybin likely have poor color perception, despite being inundated with the hallucinogenic colors.

The mechanism of how psilocybin is creating these changes is not yet known and will require further study. The researchers believe that in understanding the drug’s mechanism for temporarily re-wiring the brain and altering mood, it could potentially be manipulated into making a functional treatment for depression or other disorders. However, there is much more to be learned before it can be used in that manner.


The largest psychedelic research center in the world, and the first of its kind in the United States, will open at Johns Hopkins Medicine in Maryland. Funded by $17 million from private donors, the Center for Psychedelic and Consciousness Research will conduct research into the use of psychedelic drugs in the treatment of addiction, PTSD, depression, Alzheimer’s disease and more.

“In addition to studies on new therapeutics, we plan to investigate creativity and well-being in healthy volunteers that we hope will open up new ways to support human thriving,” Roland Griffiths, Ph. D., the center’s director and a professor at Johns Hopkins University School of Medicine, said.

The research center’s initial research has focused on psilocybin, the chemical compound found in magic mushrooms, with a broad mandate. According to a press release, researchers will investigate how psilocybin affects “behavior, brain function, learning and memory, the brain’s biology and mood.” Potential applications under investigation will include therapies for opioid addiction, Alzheimer’s, PTSD, eating disorders, alcoholism and even post-treatment Lyme disease syndrome. Clinical trials already planned for the research center include an investigation into psychedelics relation to brain function and blood biomarkers.

Psychedelic mushrooms grow in a field in England.ANDREW HASSON/GETTY IMAGES

Griffith’s psychedelic research group was first granted regulatory approval to study psychedelics in 2000. Griffith and his team conducted studies that found enduring, positive emotional effects, even months after a psilocybin experience. In one study, 67 percent of 36 patients described their psychedelic experience as one of the “most meaningful” of their lives.

“Our scientists have shown that psychedelics have real potential as medicine, and this new center will help us explore that potential,” dean of the medical faculty at Johns Hopkins, Paul B. Rothman, M.D., said.

Subsequent research has already demonstrated promising therapeutic benefits in the treatment of nicotine addiction and in mitigating the anxiety and depression associated with high mortality diseases, including cancer.

Griffith will be joined at the Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine by associate director Matthew Johnson, Ph.D.; Frederick Barrett, Ph.D.; Albert Garcia-Romeu, Ph.D.; Natalie Gukasyan, M.D.; Alan Davis, Ph.D.; Mary Cosimano, M.S.W. and William Richards, Ph.D.

“It’s been hand-to-mouth in this field, and now we have the core funding and infrastructure to really advance psychedelic science in a way that hasn’t been done before,” Griffith told the New York Times.

Donors to the center include the Steven & Alexandra Cohen Foundation, Tim Ferris, Matt Mullenweg, Blake Mycoskie and Craig Nerenberg who, combined, provided funding for five years of research conducted by six faculty neuroscientists, psychologists and clinicians, plus five postdoctoral scientists.

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.